EW Biotech
EW Biotech GmbH is a German biotech CDMO providing contract fermentation and downstream processing services from laboratory (1-5L) to commercial scale (85,000L), serving biotech, biobased chemical, and agricultural biotechnology customers via its ISO 9001:2015-certified facility in Leuna.
- Company typePrivate
- Founded2016
- HeadquartersLeuna, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What EW Biotech does
EW Biotech GmbH is a privately held German contract development and manufacturing organization (CDMO) headquartered in Leuna, Saxony-Anhalt, and a wholly-owned subsidiary of EW Nutrition GmbH (Visbek, Germany). Founded in 2016 with a technical team that has collaborated since 2012, the company operates an ISO 9001:2015-certified, multi-purpose biotech facility that delivers fermentation and downstream processing (DSP) services across the full scale ladder — from 1-5L bench reactors through 75-1,500L and 7,500-85,000L demonstration and commercial bioreactors. The plant is aseptic and aerobic, with fermentation capacity reaching an 85,000L (85m³) main fermentor and DSP covering separation (filter press, disc-stack), crossflow filtration (MF, UF, NF), SMB chromatography, ion exchange, crystallization, evaporation, spray drying, and packaging.
The core commercial offering is a vertically integrated scale-up service bundled with R&D, feasibility studies, technology transfer, and toll manufacturing, sold via direct enterprise engagement to biotech companies needing to bridge laboratory process to commercial production without building their own capital-intensive infrastructure. The Leuna bio-industrial park location provides an enabling network of long-term partners and ready access to raw materials, allowing EW Biotech to function as a single point of contact across the full program. Documented commercial-scale engagements include several tons of Genomatica's Brontide™ biobased butylene glycol (supporting awards including the 2017 ICIS Innovation Award and 2020 EPA Green Chemistry Award), 7 metric tons of Provivi's Fall Armyworm pheromone for the Pherogen™ product (covering ~400,000 hectares of corn), and over 6,000 kg of DMC Biotechnologies' L-alanine — each referencing side-by-side collaboration through planning, transfer, and execution.
EW Biotech monetizes primarily through project-based, quote-driven B2B contracts (no publicly disclosed pricing), with revenue streams spanning contract fermentation, DSP services, and contract/toll manufacturing. GTM is enterprise-direct with a single point of contact maintained throughout each customer's scale-up and production project. The company is privately held with no disclosed external funding, no public listing, and modest headcount (11-50 employees, ~30+ technologists); active hiring at the Leuna site, including a recently opened Technischer Leiter role, indicates ongoing capacity build.
EW Biotech firmographics
Firmographics- Name
- EW Biotech
- Legal name
- EW Biotech GmbH
- Website
- https://ew-biotech.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EW Biotech GmbH is a German biotech CDMO providing contract fermentation and downstream processing services from laboratory (1-5L) to commercial scale (85,000L), serving biotech, biobased chemical, and agricultural biotechnology customers via its ISO 9001:2015-certified facility in Leuna.
- Ownership category
- akta.pro rank
EW Biotech industry classification
Industry- Product category
- Biotech Contract Manufacturing
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF)
- akta.pro secondary industries
- Biorefinery Co-product Recovery, Purification & Separation (Downstream Processing Systems) (EUAAAIAN), Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media) (HLAAAJAA), Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM)
Keywords
Where EW Biotech is headquartered
LocationHeadquarters
- HQ city
- Leuna
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
EW Biotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Contract Fermentation Services: Fermentation services from lab scale to commercial production scale using their multi-purpose biotech facility. Customers include biotech companies requiring scale-up support.
- Downstream Processing (DSP): Separation, purification, and finishing services including filtration, chromatography, crystallization, drying and packaging for biotech products
- Contract Manufacturing: Toll manufacturing and sample production services at commercial scale for biotech companies
- R&D Services: Research and development support, feasibility studies, and technical consulting from early-stage development through commercial production
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
EW Biotech product offering
Product offeringCore offering
EW Biotech provides bioprocess development, scale-up, and contract manufacturing services for the biotechnology industry from its ISO9001:2015-certified multi-purpose facility in Leuna, Germany. The company's core offering spans contract fermentation (bench scale 1-5L up to commercial-scale aseptic aerobic fermentation at 85,000L), full downstream processing (separation, filtration, chromatography, crystallization, drying, packaging), contract manufacturing and toll production, R&D and feasibility studies, and access to raw materials through an enabling network of long-term partners.
Product overview
EW Biotech is a biotech contract services provider offering an integrated suite of services to bring biotech products from concept to commercial scale. The company's core offering encompasses contract fermentation and downstream processing (DSP), research and development, biomanufacturing and packaging, and access to raw materials, all delivered through their enabling network at a biotech hub in Leuna, Germany. Services are structured across three operational scales: laboratory scale (bench scale fermentation 1-5L with full QA/QC and analytical capabilities including HPLC, GC, IC), pilot and demonstration scale (75-1,500L to 7,500-85,000L bioreactors with separation, filtration, chromatography, and drying capabilities), and commercial scale (aseptic aerobic fermentation up to 85,000L with purification, crystallization, drying, and packaging). The company operates as a single complete solution provider with no modular products or sub-brands.
Differentiator
Problem solved
Functional benefit
Products and services
- Contract Fermentation Services Contract fermentation services executed at the ISO9001:2015-certified Leuna facility, spanning bench scale (1-5L), pilot and demonstration scale (75-85,000L bioreactors), and commercial-scale aseptic aerobic fermentation up to 85,000L. Designed for biotech companies needing outsourced fermentation capacity and scale-up support without building capital-intensive infrastructure themselves.
- Downstream Processing (DSP) Services Separation, purification, and finishing services covering filter press and disc-stack separation, crossflow filtration (MF, UF, NF), SMB chromatography, ion exchange, crystallization, evaporation, spray drying, and packaging. Targeted at biotech customers requiring full DSP capability as part of their scale-up and commercial production workflow.
- Contract Manufacturing (Toll Manufacturing) Toll manufacturing and sample production services at commercial scale using the Leuna facility's 85,000L fermentor and full DSP stack. Targeted at biotech companies that need commercial-scale production capacity without owning dedicated infrastructure themselves, including production of biobased chemicals, agricultural pheromones, amino acids, and related bioproducts.
- Research & Development Services Research and development, feasibility studies, and technical consulting services supporting biotech customers from early-stage development through commercial production, leveraging deep fermentation and DSP expertise and laboratory-scale (1-5L) capabilities with full QA/QC and HPLC/GC/IC analytics.
Companies that use EW Biotech
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
EW Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
EW Biotech partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- DMC BiotechnologiescoreEW Biotech partnered with DMC to demonstrate full commercial scale fermentation (85m³) and downstream processing for L-alanine production. Successfully completed purification of over 6,000 kg of product meeting customer specifications. Project executed on schedule during COVID-19 pandemic. This validated DMC's Dynamic Metabolic Control technology for commercial viability.
- ProvivicoreEW Biotech and Provivi collaborated on pheromone biosynthesis scale-up at the EW Biotech facility in Leuna, Germany. Successfully scaled up to produce 7 metric tons of Fall Armyworm pheromone component. This scale-up enabled Provivi's Pherogen™ product launch for crop protection in Mexico and Kenya, protecting approximately 400,000 hectares of corn against Fall Armyworm.
- GenomaticacoreEW Biotech played a key role in Genomatica's commercialization of Brontide™ biobased butylene glycol. Produced several tons for market sampling, validated scale-up methodologies using 85,000L fermentor. EW Biotech contributed to Genomatica's success recognized by 2017 ICIS Innovation Award and 2020 EPA Green Chemistry Award.
Scale indicators5 records
Recent moves6 records
Expansion highlights4 records
EW Biotech competitors and assessment
Company assessmentBroad incumbents
- Lonza: One of the world's largest CDMOs with extensive microbial fermentation capacity and DSP infrastructure. Competes with EWB on commercial-scale fermentation projects but operates at vastly greater scale and breadth.
- WuXi Biologics: Global CDMO with large-scale microbial and mammalian fermentation capacity. Competes for industrial biotech scale-up contracts but at significantly greater scale and geographic reach.
- Ginkgo Bioworks: Synthetic biology platform offering strain engineering and fermentation services. Competes for industrial biotech customers seeking scale-up, though differentiated by its platform/Codebase approach versus EWB's pure-service model.
Emerging players
- Codexis: Engineered enzymes and biocatalysis specialist with fermentation scale-up for protein and small-molecule products. Overlaps with EWB's customer base in biobased chemicals and specialty ingredients.
- LanzaTech: Carbon-to-product fermentation company commercializing gas-fermentation at industrial scale. Comparable commercial-scale fermentation expertise, though focused on a distinct feedstock (gas) and product slate.
Direct peers
- Biovian: Finnish biotech CDMO offering process development, scale-up, and cGMP contract manufacturing for microbial and cell-based biologics. Highly comparable in size, service scope, and European positioning to EW Biotech.
- AGC Biologics: Global CDMO providing microbial fermentation and downstream processing for biologics and biobased products. Direct competitor for industrial biotech scale-up and toll manufacturing customers.
- Selvita: European CRO/CDMO offering process development, scale-up, and contract manufacturing for biotech and pharma customers. Comparable mid-sized CDMO competing for similar industrial biotech programs.
- Capua BioServices: European-origin CDMO focused on microbial fermentation and DSP for industrial biotech customers. Comparable in scale, service scope, and target market to EW Biotech's contract manufacturing offering.
Regional players
- BRAIN Biotech: German bioeconomy company with proprietary microbial strains and bioprocess development capabilities. Geographically and functionally adjacent to EW Biotech's biobased-chemicals and DSP focus.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
EW Biotech social profiles
Digital presenceEW Biotech compliance and trust
Trust signalCompliance1 record
EW Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
EW Biotech leadership team
Management profileNumber of profiles
Profiles7 records
EW Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EW Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EW Biotech
What does EW Biotech do?
EW Biotech provides bioprocess development, scale-up, and contract manufacturing services for the biotechnology industry from its ISO9001:2015-certified multi-purpose facility in Leuna, Germany. The company's core offering spans contract fermentation (bench scale 1-5L up to commercial-scale aseptic aerobic fermentation at 85,000L), full downstream processing (separation, filtration, chromatography, crystallization, drying, packaging), contract manufacturing and toll production, R&D and feasibility studies, and access to raw materials through an enabling network of long-term partners.
Is EW Biotech a public or private company?
EW Biotech is a private company. It is classified as corporate owned and is currently operating.
When was EW Biotech founded?
EW Biotech was founded in 2016. It employs 11 to 50 people.
Where is EW Biotech based?
EW Biotech is headquartered in Leuna, Germany, in the Europe region.
How does EW Biotech make money?
Four revenue lines are on record. Contract Fermentation Services are the primary driver. The others are downstream Processing (DSP), contract Manufacturing and R&D Services.
Who are EW Biotech's main competitors?
Broad incumbents on record are Lonza, WuXi Biologics and Ginkgo Bioworks. Emerging players are Codexis and LanzaTech. Direct peers are Biovian, AGC Biologics, Selvita and Capua BioServices. BRAIN Biotech is listed as a regional player.
Does EW Biotech have an API?
No public API is recorded for EW Biotech.
What industry is EW Biotech in?
EW Biotech's product category is Biotech Contract Manufacturing. Its primary akta.pro industry code is HLAAAKAF, Process Development & Tech Transfer Services (upstream/downstream), with a secondary code of EUAAAIAN, Biorefinery Co-product Recovery, Purification & Separation (Downstream Processing Systems). Its NAICS code is 541714 and its SIC code is 8731.